The epidemiological landscape of multiple myeloma: a global cancer registry estimate of disease burden, risk factors, and temporal trends.

[1]  R. Kolhe,et al.  Epidemiology, Staging, and Management of Multiple Myeloma , 2021, Medical sciences.

[2]  L. Lipscombe,et al.  Association between diabetes and haematological malignancies: a population-based study , 2021, Diabetologia.

[3]  D. Heimburger,et al.  Cancer Control in Low- and Middle-Income Countries: Is It Time to Consider Screening? , 2019, Journal of global oncology.

[4]  G. Colditz,et al.  Body mass index throughout adulthood, physical activity, and risk of multiple myeloma: a prospective analysis in three large cohorts , 2018, British Journal of Cancer.

[5]  Gretchen A. Stevens,et al.  Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128·9 million children, adolescents, and adults , 2017, Lancet.

[6]  E. Igbigbi,et al.  Multiple myeloma in Niger Delta, Nigeria: complications and the outcome of palliative interventions , 2017, Cancer management and research.

[7]  D. Kazandjian.  Multiple myeloma epidemiology and survival: A unique malignancy. , 2016, Seminars in oncology.

[8]  O. Landgren,et al.  A look backward and forward in the regulatory and treatment history of multiple myeloma: Approval of novel-novel agents, new drug development, and longer patient survival. , 2016, Seminars in oncology.

[9]  C. la Vecchia,et al.  Alcohol drinking and multiple myeloma risk – a systematic review and meta-analysis of the dose–risk relationship , 2014, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[10]  M. Dimopoulos,et al.  Tobacco smoking and risk of multiple myeloma: A meta‐analysis of 40 observational studies , 2013, International journal of cancer.

[11]  J. Ferlay,et al.  Fifty years of cancer incidence: CI5 I–IX , 2010, International journal of cancer.

[12]  R. Tiwari,et al.  (www.interscience.wiley.com) DOI: 10.1002/sim.3733 Estimating average annual per cent change in trend analysis , 2022 .

[13]  L. Pantanowitz,et al.  Higher prevalence of monoclonal gammopathy of undetermined significance in African Americans than whites--the unknown role of underlying HIV infection. , 2006, Journal of the National Medical Association.

[14]  R. Hoover,et al.  Risk of monoclonal gammopathy of undetermined significance (MGUS) and subsequent multiple myeloma among African American and white veterans in the United States. , 2005, Blood.

[15]  Alan D. Lopez,et al.  Counting the dead and what they died from: an assessment of the global status of cause of death data. , 2005, Bulletin of the World Health Organization.

[16]  O. Nwabuko,et al.  Risk factors versus causal inferences: the implications on multiple myeloma in developed versus developing countries , 2019 .

[17]  J. Ferlay,et al.  Epidemiological patterns of leukaemia in 184 countries: a population-based study. , 2018, The Lancet. Haematology.

[18]  R. Clapp,et al.  Environmental and Occupational Causes of Cancer: New Evidence 2005-2007 , 2008, Reviews on environmental health.

[19]  K. Matsuo,et al.  Risk factors for multiple myeloma: evidence from the Japan Collaborative Cohort (JACC) study. , 2006, Asian Pacific journal of cancer prevention : APJCP.